Home›People›Josh Seidenfeld
JS

Josh Seidenfeld

Executive officer at Ambagon Therapeutics.

Executive
Updated Oct 27, 2026·Latest SEC filing Feb 7, 2025·Suggest an edit

About Josh Seidenfeld

Josh Seidenfeld is an executive officer at Ambagon Therapeutics.

Josh Seidenfeld first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Josh Seidenfeld in the role, so the role may have started earlier or lasted longer.

Ambagon Therapeutics Inc.
Executive officer
2021 – 2025 · Eindhoven, Netherlands
Develops experimental cancer drugs that stabilize interactions between proteins.

Key Colleagues at Startups

The people Josh Seidenfeld works with at each company, as listed on that company's latest Form D.

Ambagon Therapeutics Inc. · Form D, Feb 7, 2025
MM
Melissa McCracken
Partner, Nextech Invest and director
Christian Ottmann
Christian Ottmann
Co-Founder & Chief Executive Officer

Sources

  1. SECAmbagon Therapeutics Inc. Form D, filed Feb 7, 2025